The National Command and Operation Centre (NCOC) issued guidelines on Tuesday regarding safe usage of the Chinese single-dose CanSin.
As per guidelines, the CanSino vaccine will be administered to people over 18 years of age. Citizens under 18 years of age won’t be administered the single-dose CanSino COVID-19 vaccine
The NCOC has recommended that people suffering from fever and currently Covid positive should not be administered the AstraZeneca vaccine.
- Who should not receive Vaccine
- Individuals having fever at the time of coming for vaccination (Can be rescheduled after the illness is settled)
- Patients with active COVID-19
- Those with mild COVID-19 can receive the vaccine once the isolation period is complete.
- Those with severe COVID-19 can receive the vaccine once they become stable
- Individuals on short-term immunosuppressive medication should wait for 28 day after themedication ends.
- Those chronically immunosuppressed may receive the vaccine, though efficacy may be lower
- That post-transplantation may receive the vaccine 3 months after transplantation
- That post-chemotherapy may receive the vaccine 28 days after chemotherapy
- Those having severe and/or uncontrolled cardiovascular disease, respiratory disease, gastrointestinal disease, liver disease, renal disease, endocrine disorder and neurological illness.
Storage and transportation in refrigerated (2-8oC) condition
- Do not freeze the vaccine in any circumstance
- Protect the vaccine from direct exposure to sunlight
- Route of Administration: Intramuscular
- Site of Administration: Lateral Deltoid Muscle (Upper Arm), Non-dominant side
- Dose: 0.5ml/vial
- Presentation: Single-dose
- Regimen: Single shot
Federal Minister for Planning, Development, Reforms and Special Initiatives Asad Umar had said last week that Pakistan will receive 4 million doses of China’s CanSino vaccine by the end of April.